This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Barclays analyst Dan Levy downgraded the rating for General Motors Company GM from Overweight to Equal-Weight and lowered the price target from $70 to $40. General Motors shares closed at $45.14 on Monday. See how other analysts view this stock.
• Baird analyst Michael Ha downgraded HCA Healthcare, Inc. HCA from Outperform to Neutral and cut the price target from $396 to $336. HCA Healthcare shares closed at $340.62 on Monday. See how other analysts view this stock.
• Jefferies analyst Amy Li downgraded the rating for Ironwood Pharmaceuticals, Inc. IRWD from Buy to Hold and cut the price target from $8 to $0.7. Ironwood Pharmaceuticals shares closed at $0.6479 on Monday. See how other analysts view this stock.
• Jones Trading analyst Catherine Novack downgraded the rating for Rallybio Corporation RLYB from Buy to Hold. Rallybio shares closed at $0.2702 on Monday. See how other analysts view this stock.
• Barclays analyst Dan Levy downgraded Mobileye Global Inc. MBLY from Overweight to Equal-Weight and cut the price target from $22 to $14. Mobileye Global shares closed at $12.94 on Monday.  See how other analysts view this stock.

Considering buying GM stock? Here’s what analysts think:

Read This Next:

• Citigroup, Bank Of America And 3 Stocks To Watch Heading Into Tuesday

Photo via Shutterstock